Paper Details

  1. Home
  2. Paper Details

Target Therapeutic Ranges of Anti-MRSA Drugs, Linezolid, Tedizolid and Daptomycin, and the Necessity of TDM.

Author: EnokiYuki, LiuXiaoxi, MatsumotoKazuaki, MisawaKana, SaikiReika, SamuraMasaru, ShishidoShino, TaguchiKazuaki, TakemuraWataru, TashiroSho

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.

Overview

This study examined the need for therapeutic drug monitoring (TDM) for daptomycin, linezolid, and tedizolid. Linezolid showed effectiveness against pneumonia but may cause adverse reactions such as platelet count decrease, suggesting a need for TDM to optimize efficacy and minimize adverse effects. Tedizolid, on the other hand, was deemed unnecessary for TDM due to its high safety profile and effectiveness in non-severe patients. Daptomycin requires high doses to achieve efficacy and C<sub>trough</sub> monitoring to ensure safety, thus making TDM necessary.
Paper Details　
Original Abstract of the Article :
The target therapeutic ranges of vancomycin, teicoplanin, and arbekacin have been determined, and therapeutic drug monitoring (TDM) is performed in clinical practice. However, TDM is not obligatory for daptomycin, linezolid, or tedizolid. In this study, we examined whether TDM will be necessary for ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1248/bpb.b22-00276

データ提供：米国国立医学図書館（NLM）

Therapeutic Drug Monitoring: A Vital Tool in the Desert of Anti-MRSA Treatment

The battle against [methicillin-resistant Staphylococcus aureus (MRSA)] infections is a constant struggle, requiring careful consideration of treatment strategies and monitoring for optimal outcomes. This research explores the potential role of [therapeutic drug monitoring (TDM)] in guiding the use of anti-MRSA drugs, specifically [linezolid], [tedizolid], and [daptomycin]. The authors delve into the target therapeutic ranges for these drugs, examining whether TDM is necessary for effective and safe treatment.

The Importance of Monitoring for Optimal Outcomes

The authors highlight the benefits of TDM for optimizing treatment outcomes and minimizing adverse effects. They emphasize the need for careful monitoring of [linezolid] to ensure effective treatment while minimizing the risk of adverse events. They also advocate for TDM with [daptomycin] to achieve optimal efficacy and maintain safety. The findings underscore the importance of TDM as a valuable tool in managing MRSA infections.

Navigating the Complexities of Anti-MRSA Treatment

This research provides valuable insights into the complex world of anti-MRSA therapy, highlighting the importance of TDM for ensuring effective and safe treatment. The findings encourage healthcare providers to consider the potential benefits of TDM when managing patients with MRSA infections. It is crucial to consult with a healthcare professional to determine the best treatment plan for your individual needs and to understand the importance of TDM in optimizing treatment outcomes.

Dr.Camel's Conclusion

This research is like a guidebook through the vast desert of anti-MRSA treatment, providing valuable insights into the importance of TDM for optimizing patient outcomes. The findings serve as a reminder that in the fight against MRSA, vigilance and careful monitoring are essential for navigating the complexities of treatment and ensuring patient safety and well-being. The authors encourage continued research and innovation in this area, seeking to develop more effective and safer treatment strategies for MRSA infections.

Date :
  1. Date Completed 2022-07-06
  2. Date Revised 2022-07-06
Further Info :

Pubmed ID

35786589

DOI: Digital Object Identifier

10.1248/bpb.b22-00276

Related Literature

Article Analysis
・Effects of tedizolid
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.